MiRus said yesterday that it’s more than doubling its manufacturing capacity with the acquisition of a plant in its hometown.
The Marietta, Ga.-based company said the acquisition adds 50,000 sq.ft. to its existing 20,000-sq.-ft. facility. The new plant is a fully operational, 50,000-sq.-ft. orthopedic and spine manufacturing facility, MiRus said.
The company won FDA 510(k) clearance for its MoRe device in March 2019.
“MoRe superalloy approval has been greeted with great interest by surgeons, hospitals and commercial distribution channels,” founder & CEO Jay Yadav said in a press release. “To address the exploding demand for our implants, as well as the inherent capacity and lead time issues in the current medical device market, we are dramatically expanding our manufacturing capacity in Atlanta.”
MiRus also said it’s also partnering with a number of surgeons and hospital systems to develop and launch implants, robotics, navigation and analytics.
“With a view to developing market-leading products to meet clinical needs in deformity, lateral and upper extremity, we are looking to add the best implant design engineers and manufacturing engineers,” Yadav said.
